Details for Patent: 10,966,936
✉ Email this page to a colleague
Which drugs does patent 10,966,936 protect, and when does it expire?
Patent 10,966,936 protects ADLARITY and is included in one NDA.
This patent has fifteen patent family members in eleven countries.
Summary for Patent: 10,966,936
| Title: | Systems comprising a composite backing and methods for long term transdermal administration |
| Abstract: | Devices, systems, compositions and methods for long term or prolonged transdermal administration of an active agent are provided. |
| Inventor(s): | Lee; Eun Soo (Redwood City, CA), Jain; Amit K. (Milpitas, CA), Singh; Parminder (Union City, CA) |
| Assignee: | Corium, Inc. (Grand Rapids, MI) |
| Application Number: | 15/396,236 |
|
Patent Claim Types: see list of patent claims | Use; Delivery; |
Drugs Protected by US Patent 10,966,936
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Corium | ADLARITY | donepezil hydrochloride | SYSTEM;TRANSDERMAL | 212304-001 | Mar 11, 2022 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | A METHOD OF TRANSDERMAL DELIVERY OF DONEPEZIL FOR TREATING MILD, MODERATE AND SEVERE DEMENTIA OF THE ALZHEIMER'S TYPE | ⤷ Try a Trial | |||
| Corium | ADLARITY | donepezil hydrochloride | SYSTEM;TRANSDERMAL | 212304-002 | Mar 11, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | A METHOD OF TRANSDERMAL DELIVERY OF DONEPEZIL FOR TREATING MILD, MODERATE AND SEVERE DEMENTIA OF THE ALZHEIMER'S TYPE | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,966,936
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2016381351 | ⤷ Try a Trial | |||
| Australia | 2022235539 | ⤷ Try a Trial | |||
| Canada | 3010183 | ⤷ Try a Trial | |||
| China | 108697655 | ⤷ Try a Trial | |||
| European Patent Office | 3397250 | ⤷ Try a Trial | |||
| Israel | 260290 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
